| S.NO | INTERMEDIATE NAME | CASNO | PURITY/GRADE | REGULATORY APPROVALS | END PRODUCT/USE |
|---|---|---|---|---|---|
| 1 | Adapalane | 106685-40-9 | NLT 99%, USP/EP | WHO GMP | Adapalane |
| 2 | Capecetabine | 154361-50-9 | NLT 99%, USP/EP | WHO GMP | Anti cancer |
| 3 | Gemcitabin | 122111-03-9 | NLT 99%, USP/EP,IP | WHO GMP | Gemcitabin |
| 4 | Flucanazole | 86386-73-4 | NLT 99%, USP/EP/BP | WHO GMP | Anti fungal |
| 5 | Levetiracetam | 102767-28-2 | NLT 99% | WHO GMP | Levetiracetam |
| 6 | Pregabalin | 148553-50-8 | NLT 99% | WHO GMP | Pregabalin |
| 7 | 7-PHENYL ACETAMIDO-3-CHLORO METHYL CEPHALOSPORINIC ACID-4-[1-(4-METHOXY)-BENZYLESTER] (OR) GCLE | 104146-10-3 | NLT 96% | WHO GMP | Cephalosporin antibiotics |
| 8 | 7-AMINO-3-VINYL-3-CEPHEM-4-CARBOXYLIC ACID/7-AVCA | 79349-82-9 | NLT 97.5% | WHO GMP | Cefixime, 7AVCA |
| 9 | 2-n-BUTYL-4-CHLORO-5-FORMYL IMIDAZOLE (BCFI) | 83857-96-9 | NLT 99% | WHO GMP | Losartan Losartan Potassium |
| 10 | 2,4-Difluoro-alpha-(1H-1,2,4-Triazolyl)acetophenone | 86404-63-9 | NLT 99% | WHO GMP | Fluconazole, Voriconazole |
| 11 | [(2R,4R)-2-(2,4 DICHLORO PHENYL)-2-(1H-IMIDAZOL-1-YL METHYL)-1,3 DIOXOLAN-4-YL] METHYL ESTER-4-TOULENE SULFONIC ACID/CIS TOSYLATE | 2095256-87-9 | NLT 99% | WHO GMP | Ketoconazole |
| 12 | 1,1-CYCLOHEXANEDIACETIC ACID MONOAMIDE (CDMA) | 99189-60-3 | NLT 99.8% | WHO GMP | Gabapentin |
| 13 | S-2-Amino Butaramide Hydrochloride | 7682-20-4 | NLT 99.5% | WHO GMP | Levetiracetam |
| 14 | METHYL 6-[3-(1-ADAMANTY)-4-METHOXY PHENYL]-2-NAPHTHOATE | 106685-41-0 | NLT 99% | WHO GMP | Adapalene |
| 15 | 7-AMINO-3-[(Z/E)-1-YL]-3-CEPHEM-4-CARBOXYLIC ACID (OR) 7 APRA | 22252-43-3 | NLT 98.5% | WHO GMP WHO GMP | Cephalosporin antibiotics |
| 16 | 2-CHLORO-3-DIMETHYLAMINI-ALLYLIDENE-DIMETHYL-AMMONIUM; HEXAFLURO PHOSPHATE (KSM-ii) | 90536-66-6 | NLT 99.5% | WHO GMP | Hydroxyfuranones, COX-2 |
| 17 | (S)-TERT-BUTYL 4-OXO-2-(THIAZOLIDINE-3-CARBONYL)PYRROLIDINE-1-CARBOXYLATE 1-(3-METHYL-1-PHENYl-1H-PYRAZOL-5-YL)PIPERAZINE SODIUM TRIACETOXYBOROHYDRIDE | 401564-36-1, 401566-79-8, 56553-60-7 | IHS | WHO GMP | Teneligliptin |
| 18 | 1-(4-METHOXY PHENYL )-4-(4-NITROPHENYL)PIPERAZINE [4-[4-(4-METHOXY-PHENYL)-PIPERAZIN-1-YL]-PHENYL]-CARBAMIC ACID [(2R,4S)-2-(BROMOMETHYL)-2-(2,4DICHLOROPHENYL)-1,3-DIOXOLAN-4-YL]METHYL BENZOATE (CISBROMO BENZOATE) 2-SEC-BUTYL-4-{4-[4-(4-HYDROXY-PHENYL)-PIPERAZIN-1-YL]-PHENYL}-2,4-DIHYDRO-[1,2,4]TRIAZOL-3-ONE | 74852-61-2, 74853-06-8, 61397-56-6, 106461-41-0 | IHS | WHO GMP | Itraconazole |
| 19 | 5-DIFLURO METHOXY-2-MERCAPTO-1H-BENZMIDAZOLE / PANTAPRAZOLE | 97963-62-7 | IHS | WHO GMP | Pantoprazole |
| 20 | 3-TRI FLUROMETHYL-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE HYDROCHLORIDE | 762240-92-6 | NLT 99% | WHO GMP | Sitagliptin |
| 21 | 3-IODOXETANE | 26272-85-5 | NLT 98% | WHO GMP | Organic synthesis |
| 22 | OXETANE-3-OL | 7748-36-9 | NLT 97% | WHO GMP | Organic synthesis |
A dynamic stream of scientific innovation flows through our lab—driving precision technologies and empowering intelligent, data-driven discoveries.
Advancing science with high-quality chemical solutions that enable innovation, support research, and drive pharmaceutical progress.
©2025. Nikhita Laboratories. All Rights Reserved.